ArcBest Appoints Mac Pinkerton as Chief Operating Officer of Asset-Light Logistics
Mac is an experienced executive with a strong track record of driving growth and implementing positive change. He has extensive industry experience that enables him to bring value immediately. He succeeds Steven Leonard, who is retiring in June after a 24-year career with ArcBest. The asset-light organization will report to Seth Runser, president of ArcBest, in the interim between Leonard's retirement and the beginning of January.
'We're excited for Mac to join our team. He brings a depth of experience, a passion for customers and extensive supply chain knowledge,' said Judy McReynolds, ArcBest chairman and CEO. 'We're confident in his ability to drive increased value for customers and shareholders.'
Pinkerton joins ArcBest from C.H. Robinson, where he spent 28 years in various roles, most recently serving as president of North America Surface Transportation.
ABOUT ARCBEST
ArcBest® (Nasdaq: ARCB) is a multibillion-dollar integrated logistics company that helps keep the global supply chain moving. Founded in 1923 and now with 14,000 employees across 250 campuses and service centers, the company is a logistics powerhouse, using its technology, expertise and scale to connect shippers with the solutions they need — from ground, air and ocean transportation to fully managed supply chains. ArcBest has a long history of innovation that is enriched by deep customer relationships. With a commitment to helping customers navigate supply chain challenges now and in the future, the company is developing ground-breaking technology like Vaux ™, one of the TIME Best Inventions of 2023. For more information, visit arcb.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
VEON to Release 2Q25 Earnings Update on August 7, 2025
VEON to Release 2Q25 Earnings Update on August 7, 2025 Dubai, July 23, 2025 – VEON Ltd. (NASDAQ: VEON), a global digital operator, today confirms that the Group will release its selected financial and operating results for the second quarter and half-year ended June 30, 2025, at 8:00 GST (0:00 EST) on August 7, 2025. VEON will also host a results conference call with senior management at 16:00 GST (8:00 EST) on the same day. 2Q25 results conference call To register and access the event, please click here or copy and paste this link to the address bar of your browser: Once registered, a registration confirmation will be sent to the email address provided during registration with a link to access the webcast and dial-in details to listen to the conference call over the phone. We strongly encourage you to watch the event through the webcast link, but if you prefer to dial in, please use the dial-in details. Q&A If you want to participate in the Q&A session, we ask that you select the 'Yes' option on the 'Will you be asking questions live on the call?' dropdown. That will bring you to a page where you can join the Q&A room by clicking 'Connect to meeting'. You will be brought into a zoom webinar where you can listen to the presentation and once Q&A begins, if you have a question, please use the 'raise hand button' on the bottom of your zoom screen. When it is your turn to speak, the moderator will announce your name as well as sending a message to your screen asking you to confirm you want to talk. Once accepted, please unmute your mic and ask your question. To enhance engagement with the company's shareholders and facilitate connections with its investors, VEON is partnering with Say Technologies to allow retail and institutional shareholders to submit and upvote questions, a selection of which will be answered by VEON management during the results conference call. Starting on July 31, 2025, at 8:00 EST, the Q&A platform will become available, and all shareholders will be able to submit and upvote questions for VEON management by visiting: This Q&A platform will remain open until 24 hours before the trading update conference call. Shareholders can email support@ for any support inquiries. You can also submit your questions prior the event to VEON Investor Relations at ir@ We look forward to your participation. About VEONVEON is a digital operator that provides converged connectivity and digital services to nearly 160 million customers. Operating across six countries that are home to more than 7% of the world's population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on Nasdaq. For more information visit: DisclaimerThis press release contains 'forward-looking statements', as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, expectations regarding management plans and the ability to successfully execute VEON's operating model as well as its governance, strategic and development plans. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events. Contact informationVEONInvestor Relationsir@
Business Wire
6 minutes ago
- Business Wire
Corstasis Therapeutics Announces Appointment of Sanjeev Narula to its Strategic Advisory Board
HENDERSON, Nev.--(BUSINESS WIRE)--Corstasis Therapeutics Inc. ( a late clinical-stage innovator of therapies that enhance options for the treatment of fluid overload in patients with cardiorenal and hepatic diseases, with the intent of lowering the overall cost of care, today announced that life science executive Sanjeev Narula has joined the company's Strategic Advisory Board. Corstasis Therapeutics Announces Appointment of Sanjeev Narula to its Strategic Advisory Board Share 'Sanjeev's extensive strategic, financial and operational experience in large commercial-stage pharmaceutical companies make him a tremendous addition to our strategic advisory board,' said Benjamin Esque, Chairman and Chief Executive Officer of Corstasis Therapeutics Inc. 'We expect Corstasis will benefit greatly from Sanjeev's advice as we prepare our commercial strategy and pre-launch activities for Enbumyst™ ahead of its potential approval in September.' Mr. Narula most recently served as the Chief Financial Officer of Intra-Cellular Therapies, Inc., which he joined in 2024. During his tenure, he played a crucial role in expanding the commercial and operational capabilities of the company , which culminated in the successful acquisition of Intra-Cellular Therapies by Johnson & Johnson for $14.6 billion less than a year later. Before Intra-Cellular, Mr. Narula served as the first Chief Financial Officer of Viatris, which he joined in 2020 when the company was formed through the combination of Mylan and Upjohn, a division of Pfizer Inc. Prior to Viatris, he served as Chief Financial Officer at Upjohn, overseeing finance, procurement and business technology for all functions of the business, and held several other financial leadership positions during his 16 years at Pfizer. 'I am excited to join Corstasis as a strategic advisor at this critical inflection point in the company's journey, and look forward to contributing to its growth and capital strategy as it prepares for the potential launch of Enbumyst™,' said Mr. Narula. About Corstasis Therapeutics Corstasis Therapeutics is a late clinical-stage biopharmaceutical company whose mission is to develop and commercialize enhanced outpatient treatment options for patients with cardiorenal and hepatic diseases, with the intent of improving outcomes and reducing overall healthcare costs. Our lead product, Enbumyst™ bumetanide nasal spray, has been developed for the short-term treatment of edema associated with congestive heart failure, liver and kidney disease, with an anticipated PDUFA action date of September 14, 2025. For more information, please visit
Business Wire
6 minutes ago
- Business Wire
FFAI Marks Fourth Anniversary of Nasdaq Listing with Commitment to Accelerate FX Product Execution and Delivery, Uphold 'Stockholders First' Principle, and Continue the Counterattack Against Potential Illegal Short Selling
LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ('Faraday Future', 'FF' or the 'Company'), a California-based global shared intelligent electric mobility ecosystem company, today announced the celebration of its fourth anniversary as a publicly listed company on Nasdaq. Marking this milestone, the Company reaffirmed its commitment to driving breakthroughs in both its business and capital fundamentals. FF also pledged to accelerate the execution and delivery of products under its second brand, FX, while advancing its dual-brand strategy. Upholding its 'Stockholders First' philosophy, the Company remains focused on delivering greater value to stockholders by expediting efforts to win the Counterattack Against Potential Illegal Short Selling and maximizing stockholder interests. Faraday Future Marks Fourth Anniversary with a Reversal in Both Business and Capital Fundamentals Since its successful listing in 2021, FF has remained focused on disruptive innovation in the intelligent electric mobility ecosystem and is now advancing from the AIEV era to the next-generation EAI EV era. Following the return of the founding team—including Founder YT Jia—in April this year, the Company has implemented a comprehensive 'Ten Punch Combo' transformations, achieving a qualitative leap across key areas such as product development and delivery, manufacturing, supply chain, brand building, organizational governance, and system and capability buildup. On July 17, FF successfully unveiled in Downtown Los Angeles the FX Super One, alongside the Super EAI F.A.C.E. (Front AI Communication Ecosystem), and the FF EAI Embodied AI Agent 6x4 Architecture. The debut of the FX Super One made a striking market impression, fundamentally redefining the traditional luxury executive mobility experience long dominated by models such as the Cadillac Escalade. Compared to where the Company stood at the time of its IPO four years ago, FF has now achieved a dual turnaround in both business and capital fundamentals. The Company has established a strategic framework centered around dual home markets and dual DNA in U.S. and China, while also deploying its 'Third Pole' in Middle East. Through consistent delivery on its promises, more transparent communications, and a proactive and pragmatic corporate culture, FF has regained a vote of confidence from its stockholders. Since its debut, the FX Super One has attracted significant market attention, with over 10,000 paid pre-orders from both B2B and B2C customers. FF continues to refine its Co-Creation Ecosystem Online Direct Sales system, expand its multi-channel sales strategy, and elevate brand influence. The Company's 'B2B2C' co-creation ecosystem model now covers five core sectors: FX Par (Partners), car rental companies, live e-commerce MCN agencies, real estate brokerages, and home office industry. On July 21, the Company also announced a strategic partnership with HabitTrade, a global multi-market brokerage and digital asset infrastructure platform. Through this collaboration, FF seeks to build an integrated ecosystem combining EAI mobility, Web3, blockchain technology, crypto, and stablecoin applications. This initiative aims to bridge Web2 and Web3, connect on-chain and off-chain value flows, and expand the convergence between the real and virtual economies—creating new value for both users and the industry. In addition, the Company recently completed a new round of financing commitment totaling $105 million, which is expected to nearly cover the launch requirements of the FX Super One. Global institutional investor BlackRock has increased its holdings in FFAI for four consecutive quarters, reaching 5.39 million shares, signaling growing recognition and confidence among top-tier capital in the outlook of both FF and FX. Initial Victory in the Counterattack Against Potential Illegal Short Selling; FF Reaffirms Its Commitment to Protecting Stockholder Interests Since the appointment of Founder YT Jia as FF's Co-CEO, the Company has achieved initial success in its efforts to combat potential illegal short selling. The Company previously issued a public update on the identified illegal short selling and online market manipulation targeting FFAI, noting that certain individuals and online accounts involved had issued public apologies and taken down all content suspected of contributing to such manipulative activities. Recently, the Company identified additional indications of potential illegal short selling and the deliberate dissemination of false or misleading information aimed at disrupting the market. FF has issued a legal letter to the parties involved and reserves all rights to pursue legal remedies. On the occasion of its fourth anniversary as a publicly listed company, FF reaffirms its unwavering commitment to the 'Stockholders First' philosophy and its effort to continue to closely monitor the market for signs of potential illegal short selling and will take all necessary legal and regulatory actions to defend the rights and interests of its stockholders. Any attempts to undermine FFAI or harm investor interests will be met with appropriate consequences. FF also calls on regulators and the broader investment community to remain vigilant against such bad-faith efforts to distort capital markets. The Company urges collective resistance against the malicious attacks and defamatory campaigns launched by irresponsible entities targeting innovative enterprises. ABOUT FARADAY FUTURE Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company's mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future's flagship model, the FF 91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit FORWARD LOOKING STATEMENTS This press release includes 'forward looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words 'plan to,' 'can,' 'will,' 'should,' 'future,' 'potential,' and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding the Super One MPV, Super EAI F.A.C.E., and EAI Embodied AI Agent 6x4 architecture, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include, among others: the Company's ability to secure necessary agreements to license or produce FX vehicles in the U.S., the Middle East, or elsewhere, none of which have been secured; the Company's ability to homologate FX vehicles for sale in the U.S., the Middle East, or elsewhere; the Company's ability to secure the necessary funding to execute on its AI, EREV and Faraday X (FX) strategies, each of which will be substantial; the Company's ability to secure necessary permits at its Hanford, CA production facility; the Company's ability to secure regulatory approvals for the proposed Super One front grill; the potential impact of tariff policy; the Company's ability to continue as a going concern and improve its liquidity and financial position; the Company's ability to pay its outstanding obligations; the Company's ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company's limited operating history and the significant barriers to growth it faces; the Company's history of losses and expectation of continued losses; the success of the Company's payroll expense reduction plan; the Company's ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company's estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company's vehicles; the Company's ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company's vehicles; current and potential litigation involving the Company; uncertainties regarding the Company's legal remedies related to illegal short selling, market manipulation, or false information, and the unpredictability of judicial interpretations or regulatory responses; the Company's ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company's indebtedness; the Company's ability to cover future warranty claims; the Company's ability to use its 'at-the-market' program; insurance coverage; general economic and market conditions impacting demand for the Company's products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company's control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company's operations in China; the success of the Company's remedial measures taken in response to the Special Committee findings; the Company's dependence on its suppliers and contract manufacturer; the Company's ability to develop and protect its technologies; the Company's ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company's stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the 'Risk Factors' section of the Company's Form 10-K filed with the SEC on March 31, 2025, and other documents filed by the Company from time to time with the SEC.
